指南与共识神经介入MR

美国立体定向与功能神经外科学会:聚焦超声脑损毁须由神经外科医师实施

Position Statement of the American Society for Stereotactic and Functional Neurosurgery on Focused Ultrasound Lesioning of the Brain by Non-neurosurgeons.
指南 / 共识 · Neurosurgery · 2025-12-04

本立场声明针对MR引导聚焦超声(MRgFUS)脑损毁术的资质问题。学会回顾MRgFUS自2016年获FDA批准用于特发性震颤后适应证逐渐扩大。基于手术属性、培训要求及现有证据来源,声明只有经过功能神经外科训练的神经外科医师才能实施MRgFUS手术性损毁。

要点

  • MRgFUS脑损毁本质上是手术干预,阅片时应注意其术后改变属手术性病变而非单纯治疗反应。
  • 目前已批准适应证包括单侧丘脑切开术治疗特发性震颤和帕金森病震颤,以及分期双侧丘脑切开术治疗特发性震颤。
  • 所有关于MRgFUS治疗运动障碍安全性和有效性的高级别证据均来自神经外科医师操作,影像解读时应了解操作者背景。

核心结论

  • 学会立场声明认为只有经过适当功能神经外科训练的神经外科医师才应实施MRgFUS手术性损毁。

研究设计与样本

  • 该文献为美国立体定向与功能神经外科学会(ASSFN)代表美国神经外科医师大会(CNS)和美国神经外科医师协会(AANS)发布的立场声明。
  • 声明基于MRgFUS自2016年获美国FDA批准用于特发性震颤后临床应用扩展的背景提出,未报告系统检索或证据分级方法。

诊断标准与关键数值

  • 已批准应用包括单侧丘脑切开术治疗特发性震颤和帕金森病震颤,以及分期双侧丘脑切开术治疗特发性震颤。
  • 学会提出资质标准为:必须是经过适当训练以开展功能神经外科手术的神经外科医师。

临床应用与阅片要点

  • 放射科和超声科医师应知晓MRgFUS丘脑损毁属于手术性干预,涉及多学科运动障碍团队协作。
  • 报告中应注意该技术从大型学术中心向其他医疗环境扩展,需关注操作者培训和责任相关问题。

局限性

  • 目前所有关于MRgFUS损毁治疗运动障碍安全性和有效性的高级别证据均来自神经外科医师操作,结果可能无法推广到其他医师。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Since its US Food and Drug Administration approval in 2016, magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy has grown into one of the procedures of choice among patients with essential tremor (ET). Approved applications for the procedure have expanded over time from unilateral thalamotomy to treat ET and Parkinson disease tremor to bilateral staged thalamotomy for ET. As the procedure expands to healthcare environments beyond large academic centers, guidance is required to ensure that the responsible clinicians are appropriately trained to undertake this operative procedure. Although multidisciplinary movement disorder teams are important for the optimal management of patients, MRgFUS lesions are inherently surgical interventions. Neurosurgeons are trained to evaluate these patients, consider surgical alternatives and conduct these operations, particularly after completing a fellowship in the subspecialty of stereotactic and functional neurosurgery. At present, all high-level evidence regarding the safety and efficacy of MRgFUS lesions to treat movement disorders derives from procedures performed by neurosurgeons, so those results may not be generalizable to other physicians. Based on these considerations and potential liability issues, the American Society for Stereotactic and Functional Neurosurgery, which acts as the joint section representing the field of stereotactic and functional neurosurgery on behalf of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons, puts forth this position statement that only neurosurgeons appropriately trained to conduct functional neurosurgery procedures should conduct MRgFUS surgical lesions.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Danish, Rosenow, Schwalb, et al. Position Statement of the American Society for Stereotactic and Functional Neurosurgery on Focused Ultrasound Lesioning of the Brain by Non-neurosurgeons. Neurosurgery. 2025. PMID: 42341199. doi:10.1227/neu.0000000000003869

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。